ADHERENCE to statin therapy
has been associated with increased
risk of diabetes type 2, according to
a new observational study.
The authors of the research,
which involved 115,709
participants, concluded that even
though in the real world setting,
the risk of new-onset diabetes rises
as adherence with statin therapy
increases, the benefits of statins in
reducing cardiovascular events still
overwhelmed the diabetes risk.
CLICK HERE to source the abstract.The above article was sent to subscribers in Pharmacy Daily's issue from 21 Jul 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Jul 14
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.